Abstract
Background
The purpose of this study was to review the incidence of incidental gastrointestinal stromal tumors (GISTs) in a cohort of morbidly obese patients undergoing laparoscopic sleeve gastrectomy (LSG) or Roux-en-Y gastric bypass (RYGB), analyzing surgery indication, morbidity, and follow-up data.
Methods
All cases with incidental GISTs found were reviewed.
Results
Two thousand six hundred three patients underwent obesity surgery founding a gastric GIST in eight patients (incidence 0.31 %). Mean tumor size was 7.65 mm (range 2.5–13 mm) with the majority of the lesions located in the fundus of the stomach. All lesions had negative resection margins. At a mean follow-up of 30 months, all patients were disease-free.
Conclusion
The long-term disease-free survival of 100 % in our study establishes laparoscopic wedge resection during RYGB and LSG as safe and effective in treating incidental gastric GISTs <2 cm.
Abbreviations
- BMI:
-
Body mass index
- LSG:
-
Laparoscopic sleeve gastrectomy
- RYGB:
-
Roux-en-Y gastric bypass
- GIST:
-
Gastrointestinal stromal tumor
- SEER:
-
Surveillance, Epidemiology, and End Results
- NCCN:
-
National Comprehensive Cancer Network
- ESMO:
-
European Society for Medical Oncology
- BII-bypass:
-
Billroth II-bypass (Omega loop gastric bypass)
- CT:
-
Computed tomography
- HPF:
-
High-power fields
- SD:
-
Standard deviation
- HP:
-
Helicobacter pylori
- MRI:
-
Magnetic resonance imaging
References
Blay JY, von Mehren M, Blackstein ME. Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors. Cancer. 2010;116(22):5126–37.
Demetri GD, Benjamin RS, Blanke CD, et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)—update of the NCCN clinical practice guidelines. J Natl Compr Cancer Netw. 2007;5 Suppl 2:S1–S29.
Demetri GD, von Mehren M, Antonescu CR, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Cancer Netw. 2010;8 Suppl 2:S1–S41.
Tryggvason G, Gislason HG, Magnusson MK, et al. Gastrointestinal stromal tumors in Iceland, 1990–2003: the Icelandic GIST study, a population-based incidence and pathologic risk stratification study. Int J Cancer. 2005;117:289–93.
Goettsch WG, Bos SD, Breekveldt-Postma N, et al. Incidence of gastrointestinal stromal tumors is underestimated: results of a nation-wide study. Eur J Cancer. 2005;41:2868–72.
Rubió J, Marcos-Gragera R, Ortiz MR, et al. Population-based incidence and survival of gastrointestinal stromal tumors (GIST) in Girona, Spain. Eur J Cancer. 2007;43:144–8.
Nilsson B, Bümming P, Meis-Kindblom JM, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era—a population based study in western Sweden. Cancer. 2005;103:821–9.
Scherübl H, Faiss S, Knoefel WT, et al. Management of early asymptomatic gastrointestinal stromal tumors of the stomach. World J Gastrointest Endosc. 2014;6(7):266–71.
Agaimy A, Vassos N, Croner RS. Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen’s disease): clinicopathological spectrum with pathogenetic considerations. Int J Clin Exp Pathol. 2012;5(9):852–62.
Fong Y, Coit DG, Woodruff JM, et al. Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg. 1993;217:72–7.
Blackstein ME, Blay JY, Corless C, et al. Canadian advisory committee on GIST gastrointestinal stromal tumours: consensus statement on diagnosis and treatment. Can J Gastroenterol. 2006;20(3):157–63.
Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36.
Raghavendra RS, Kini D. Benign, premalignant, and malignant lesions encountered in bariatric surgery. JSLS. 2012;16(3):360–72.
Yuval JB, Khalaileh A, Abu-Gazala M, et al. The true incidence of gastric GIST—a study based on morbidly obese patients undergoing sleeve gastrectomy. Obes Surg. 2014;24(12):2134–7.
Yun HY, Sung R, Kim YC, et al. Regional distribution of interstitial cells of Cajal (ICC) in human stomach. Korean. J Physiol Pharmacol. 2010;14:317–24.
Bhaskaran K, Douglas I, Forbes H, et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet. 2014;384(9945):755–65.
Sanchez BR, Morton JM, Curet MJ, et al. Incidental finding of gastrointestinal stromal tumors (GISTs) during laparoscopic gastric bypass. Obes Surg. 2005;15(10):1384–8.
Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29(1):52–68.
Casali PG, Jost L, Reichardt P, et al. ESMO Guidelines Working Group. Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20 Suppl 4:64–7.
Huang Z, Li Y, Zhao H, et al. Prognositic factors and clinicopathologic characteristics of small gastrointestinal stromal tumor of the stomach: a retrospective analysis of 31 cases in one center. Cancer Biol Med. 2013;10(3):165–8.
van der Zwan SM, DeMatteo RP. Gastrointestinal stromal tumor: 5 years later. Cancer. 2005;104(9):1781–8.
Disclosure
Drs. S. Chiappetta, S. Theodoridou, C. Stier, and R.A. Weiner have no conflicts of interest or financial ties to disclose.
Statement of Informed Consent
Informed consent was obtained from all individual participants included in the study.
Statement of Human and Animal Rights
For this type of study, formal consent was not required.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chiappetta, S., Theodoridou, S., Stier, C. et al. Incidental Finding of GIST During Obesity Surgery. OBES SURG 25, 579–583 (2015). https://doi.org/10.1007/s11695-015-1571-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-015-1571-4